{"entity":{"type":"insider","cik":"0001727606","url":"/insider/0001727606","json_url":"/insider/0001727606.json","name":"ROBERTS EIRY","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":40,"n_filings":25,"first":"2019-01-10","last":"2025-02-14","span_basis":"filed_date"},"name_variants":[{"name":"ROBERTS EIRY","source":"filing","n_filings":25,"first_seen":"2019-01-10","last_seen":"2025-02-14"}],"transactions":[{"id":4091145,"accession":"0000914475-25-000069","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000914475-25-000069","line_url":"/filing/0000914475-25-000069#line-6","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001727606","owner_name":"ROBERTS EIRY","owner_display_name":"ROBERTS EIRY","owner_url":"/insider/0001727606","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":115.0425,"price_display":"115.04","price_state":"stated","total_value":57521.25,"total_display":"57,521.25","total_whole":"57,521","shares_owned_after":35640.0,"shares_owned_after_display":"35,640","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-14","filed_date":"2025-02-14","scope":"insider"},{"id":4091141,"accession":"0000914475-25-000069","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000914475-25-000069","line_url":"/filing/0000914475-25-000069","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001727606","owner_name":"ROBERTS EIRY","owner_display_name":"ROBERTS EIRY","owner_url":"/insider/0001727606","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1718.0,"shares_display":"1,718","price_per_share":116.84660942956927,"price_display":"116.85","price_state":"stated","total_value":200742.475,"total_display":"200,742.48","total_whole":"200,742","shares_owned_after":34252.0,"shares_owned_after_display":"34,252","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-13","filed_date":"2025-02-14","scope":"insider","n_lines":2},{"id":4026942,"accession":"0000914475-25-000051","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000914475-25-000051","line_url":"/filing/0000914475-25-000051#line-2","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001727606","owner_name":"ROBERTS EIRY","owner_display_name":"ROBERTS EIRY","owner_url":"/insider/0001727606","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":980.0,"shares_display":"980","price_per_share":118.217,"price_display":"118.22","price_state":"stated","total_value":115852.66,"total_display":"115,852.66","total_whole":"115,853","shares_owned_after":33253.0,"shares_owned_after_display":"33,253","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-10","filed_date":"2025-02-12","scope":"insider"},{"id":5190290,"accession":"0000914475-25-000029","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000914475-25-000029","line_url":"/filing/0000914475-25-000029#line-2","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001727606","owner_name":"ROBERTS EIRY","owner_display_name":"ROBERTS EIRY","owner_url":"/insider/0001727606","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1457.0,"shares_display":"1,457","price_per_share":152.8045,"price_display":"152.80","price_state":"stated","total_value":222636.1565,"total_display":"222,636.16","total_whole":"222,636","shares_owned_after":32373.0,"shares_owned_after_display":"32,373","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-31","filed_date":"2025-02-04","scope":"insider"},{"id":2413381,"accession":"0000914475-24-000076","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000914475-24-000076","line_url":"/filing/0000914475-24-000076#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001727606","owner_name":"ROBERTS EIRY","owner_display_name":"ROBERTS EIRY","owner_url":"/insider/0001727606","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1114.0,"shares_display":"1,114","price_per_share":132.9639,"price_display":"132.96","price_state":"stated","total_value":148121.7846,"total_display":"148,121.78","total_whole":"148,122","shares_owned_after":23716.0,"shares_owned_after_display":"23,716","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-13","filed_date":"2024-02-15","scope":"insider"},{"id":2720582,"accession":"0000914475-24-000049","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000914475-24-000049","line_url":"/filing/0000914475-24-000049#line-2","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001727606","owner_name":"ROBERTS EIRY","owner_display_name":"ROBERTS EIRY","owner_url":"/insider/0001727606","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":980.0,"shares_display":"980","price_per_share":134.2061,"price_display":"134.21","price_state":"stated","total_value":131521.978,"total_display":"131,521.98","total_whole":"131,522","shares_owned_after":22717.0,"shares_owned_after_display":"22,717","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-08","filed_date":"2024-02-08","scope":"insider"},{"id":2720571,"accession":"0000914475-24-000049","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000914475-24-000049","line_url":"/filing/0000914475-24-000049#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001727606","owner_name":"ROBERTS EIRY","owner_display_name":"ROBERTS EIRY","owner_url":"/insider/0001727606","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1121.0,"shares_display":"1,121","price_per_share":142.2356,"price_display":"142.24","price_state":"stated","total_value":159446.1076,"total_display":"159,446.11","total_whole":"159,446","shares_owned_after":21837.0,"shares_owned_after_display":"21,837","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-06","filed_date":"2024-02-08","scope":"insider"},{"id":2500394,"accession":"0000914475-24-000031","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000914475-24-000031","line_url":"/filing/0000914475-24-000031#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001727606","owner_name":"ROBERTS EIRY","owner_display_name":"ROBERTS EIRY","owner_url":"/insider/0001727606","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1457.0,"shares_display":"1,457","price_per_share":140.7906,"price_display":"140.79","price_state":"stated","total_value":205131.9042,"total_display":"205,131.90","total_whole":"205,132","shares_owned_after":20832.0,"shares_owned_after_display":"20,832","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-31","filed_date":"2024-02-02","scope":"insider"},{"id":8156770,"accession":"0001209191-23-059774","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-059774","line_url":"/filing/0001209191-23-059774#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001727606","owner_name":"ROBERTS EIRY","owner_display_name":"ROBERTS EIRY","owner_url":"/insider/0001727606","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":126.7448,"price_display":"126.74","price_state":"stated","total_value":1267448.0,"total_display":"1,267,448.00","total_whole":"1,267,448","shares_owned_after":19521.0,"shares_owned_after_display":"19,521","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-22","filed_date":"2023-12-27","scope":"insider"},{"id":8079646,"accession":"0001209191-23-058683","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-058683","line_url":"/filing/0001209191-23-058683","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001727606","owner_name":"ROBERTS EIRY","owner_display_name":"ROBERTS EIRY","owner_url":"/insider/0001727606","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13925.0,"shares_display":"13,925","price_per_share":120.30449243087972,"price_display":"120.30","price_state":"stated","total_value":1675240.0571,"total_display":"1,675,240.06","total_whole":"1,675,240","shares_owned_after":29521.0,"shares_owned_after_display":"29,521","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-12","filed_date":"2023-12-14","scope":"insider","n_lines":2},{"id":8374248,"accession":"0001209191-23-058116","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001209191-23-058116","line_url":"/filing/0001209191-23-058116","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001727606","owner_name":"ROBERTS EIRY","owner_display_name":"ROBERTS EIRY","owner_url":"/insider/0001727606","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":120.10333333333334,"price_display":"120.10","price_state":"stated","total_value":36031.0,"total_display":"36,031.00","total_whole":"36,031","shares_owned_after":29521.0,"shares_owned_after_display":"29,521","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-08","filed_date":"2023-12-11","scope":"insider","n_lines":2},{"id":8374231,"accession":"0001209191-23-058116","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-23-058116","line_url":"/filing/0001209191-23-058116","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001727606","owner_name":"ROBERTS EIRY","owner_display_name":"ROBERTS EIRY","owner_url":"/insider/0001727606","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":77379.0,"shares_display":"77,379","price_per_share":120.37270100802543,"price_display":"120.37","price_state":"stated","total_value":9314319.2313,"total_display":"9,314,319.23","total_whole":"9,314,319","shares_owned_after":29521.0,"shares_owned_after_display":"29,521","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-07","filed_date":"2023-12-11","scope":"insider","n_lines":4},{"id":8502590,"accession":"0001209191-23-057986","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-057986","line_url":"/filing/0001209191-23-057986#line-2","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001727606","owner_name":"ROBERTS EIRY","owner_display_name":"ROBERTS EIRY","owner_url":"/insider/0001727606","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8396.0,"shares_display":"8,396","price_per_share":120.031,"price_display":"120.03","price_state":"stated","total_value":1007780.276,"total_display":"1,007,780.28","total_whole":"1,007,780","shares_owned_after":29521.0,"shares_owned_after_display":"29,521","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-06","filed_date":"2023-12-08","scope":"insider"},{"id":8546750,"accession":"0001209191-23-047140","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-047140","line_url":"/filing/0001209191-23-047140#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001727606","owner_name":"ROBERTS EIRY","owner_display_name":"ROBERTS EIRY","owner_url":"/insider/0001727606","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3198.0,"shares_display":"3,198","price_per_share":107.3758,"price_display":"107.38","price_state":"stated","total_value":343387.8084,"total_display":"343,387.81","total_whole":"343,388","shares_owned_after":29521.0,"shares_owned_after_display":"29,521","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-21","filed_date":"2023-08-23","scope":"insider"},{"id":8607196,"accession":"0001209191-23-025763","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-025763","line_url":"/filing/0001209191-23-025763#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001727606","owner_name":"ROBERTS EIRY","owner_display_name":"ROBERTS EIRY","owner_url":"/insider/0001727606","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14400.0,"shares_display":"14,400","price_per_share":103.4763,"price_display":"103.48","price_state":"stated","total_value":1490058.72,"total_display":"1,490,058.72","total_whole":"1,490,059","shares_owned_after":26644.0,"shares_owned_after_display":"26,644","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-24","filed_date":"2023-04-26","scope":"insider"},{"id":8627376,"accession":"0001209191-23-007916","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-007916","line_url":"/filing/0001209191-23-007916#line-4","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001727606","owner_name":"ROBERTS EIRY","owner_display_name":"ROBERTS EIRY","owner_url":"/insider/0001727606","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":980.0,"shares_display":"980","price_per_share":104.1551,"price_display":"104.16","price_state":"stated","total_value":102071.998,"total_display":"102,072.00","total_whole":"102,072","shares_owned_after":41015.0,"shares_owned_after_display":"41,015","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-08","filed_date":"2023-02-08","scope":"insider"},{"id":8627374,"accession":"0001209191-23-007916","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-007916","line_url":"/filing/0001209191-23-007916","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001727606","owner_name":"ROBERTS EIRY","owner_display_name":"ROBERTS EIRY","owner_url":"/insider/0001727606","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14424.0,"shares_display":"14,424","price_per_share":102.40103005407654,"price_display":"102.40","price_state":"stated","total_value":1477032.4575,"total_display":"1,477,032.46","total_whole":"1,477,032","shares_owned_after":40135.0,"shares_owned_after_display":"40,135","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-07","filed_date":"2023-02-08","scope":"insider","n_lines":2},{"id":8627364,"accession":"0001209191-23-007916","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-007916","line_url":"/filing/0001209191-23-007916#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001727606","owner_name":"ROBERTS EIRY","owner_display_name":"ROBERTS EIRY","owner_url":"/insider/0001727606","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1121.0,"shares_display":"1,121","price_per_share":105.8004,"price_display":"105.80","price_state":"stated","total_value":118602.2484,"total_display":"118,602.25","total_whole":"118,602","shares_owned_after":27176.0,"shares_owned_after_display":"27,176","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-06","filed_date":"2023-02-08","scope":"insider"},{"id":8151276,"accession":"0001209191-23-006282","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-006282","line_url":"/filing/0001209191-23-006282#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001727606","owner_name":"ROBERTS EIRY","owner_display_name":"ROBERTS EIRY","owner_url":"/insider/0001727606","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1457.0,"shares_display":"1,457","price_per_share":109.9887,"price_display":"109.99","price_state":"stated","total_value":160253.5359,"total_display":"160,253.54","total_whole":"160,254","shares_owned_after":26171.0,"shares_owned_after_display":"26,171","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-31","filed_date":"2023-02-02","scope":"insider"},{"id":6120221,"accession":"0001209191-22-008216","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-22-008216","line_url":"/filing/0001209191-22-008216#line-3","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001727606","owner_name":"ROBERTS EIRY","owner_display_name":"ROBERTS EIRY","owner_url":"/insider/0001727606","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":980.0,"shares_display":"980","price_per_share":79.521,"price_display":"79.52","price_state":"stated","total_value":77930.58,"total_display":"77,930.58","total_whole":"77,931","shares_owned_after":24625.0,"shares_owned_after_display":"24,625","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-08","filed_date":"2022-02-09","scope":"insider"},{"id":6120218,"accession":"0001209191-22-008216","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-008216","line_url":"/filing/0001209191-22-008216","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001727606","owner_name":"ROBERTS EIRY","owner_display_name":"ROBERTS EIRY","owner_url":"/insider/0001727606","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2744.0,"shares_display":"2,744","price_per_share":80.77981497813411,"price_display":"80.78","price_state":"stated","total_value":221659.8123,"total_display":"221,659.81","total_whole":"221,660","shares_owned_after":22741.0,"shares_owned_after_display":"22,741","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-07","filed_date":"2022-02-09","scope":"insider","n_lines":2},{"id":6692917,"accession":"0001209191-22-003104","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-003104","line_url":"/filing/0001209191-22-003104#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001727606","owner_name":"ROBERTS EIRY","owner_display_name":"ROBERTS EIRY","owner_url":"/insider/0001727606","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2632.0,"shares_display":"2,632","price_per_share":74.5014,"price_display":"74.50","price_state":"stated","total_value":196087.6848,"total_display":"196,087.68","total_whole":"196,088","shares_owned_after":21279.0,"shares_owned_after_display":"21,279","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-10","filed_date":"2022-01-12","scope":"insider"},{"id":4553603,"accession":"0001209191-21-009123","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-009123","line_url":"/filing/0001209191-21-009123","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001727606","owner_name":"ROBERTS EIRY","owner_display_name":"ROBERTS EIRY","owner_url":"/insider/0001727606","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2363.0,"shares_display":"2,363","price_per_share":116.77694185357596,"price_display":"116.78","price_state":"stated","total_value":275943.9136,"total_display":"275,943.91","total_whole":"275,944","shares_owned_after":18693.0,"shares_owned_after_display":"18,693","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-08","filed_date":"2021-02-09","scope":"insider","n_lines":2},{"id":4715353,"accession":"0001209191-21-003239","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-003239","line_url":"/filing/0001209191-21-003239#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001727606","owner_name":"ROBERTS EIRY","owner_display_name":"ROBERTS EIRY","owner_url":"/insider/0001727606","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2632.0,"shares_display":"2,632","price_per_share":111.0552,"price_display":"111.06","price_state":"stated","total_value":292297.2864,"total_display":"292,297.29","total_whole":"292,297","shares_owned_after":15845.0,"shares_owned_after_display":"15,845","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-08","filed_date":"2021-01-12","scope":"insider"},{"id":2049434,"accession":"0001209191-20-058553","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-058553","line_url":"/filing/0001209191-20-058553#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001727606","owner_name":"ROBERTS EIRY","owner_display_name":"ROBERTS EIRY","owner_url":"/insider/0001727606","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2257.0,"shares_display":"2,257","price_per_share":90.7443,"price_display":"90.74","price_state":"stated","total_value":204809.8851,"total_display":"204,809.89","total_whole":"204,810","shares_owned_after":13477.0,"shares_owned_after_display":"13,477","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-12","filed_date":"2020-11-16","scope":"insider"},{"id":2111529,"accession":"0001209191-20-045771","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-045771","line_url":"/filing/0001209191-20-045771#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001727606","owner_name":"ROBERTS EIRY","owner_display_name":"ROBERTS EIRY","owner_url":"/insider/0001727606","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2257.0,"shares_display":"2,257","price_per_share":118.8415,"price_display":"118.84","price_state":"stated","total_value":268225.2655,"total_display":"268,225.27","total_whole":"268,225","shares_owned_after":11446.0,"shares_owned_after_display":"11,446","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-05","filed_date":"2020-08-07","scope":"insider"},{"id":2832548,"accession":"0001209191-20-038896","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-038896","line_url":"/filing/0001209191-20-038896#line-2","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001727606","owner_name":"ROBERTS EIRY","owner_display_name":"ROBERTS EIRY","owner_url":"/insider/0001727606","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":130.0,"price_display":"130.00","price_state":"stated","total_value":650000.0,"total_display":"650,000.00","total_whole":"650,000","shares_owned_after":9416.0,"shares_owned_after_display":"9,416","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-23","filed_date":"2020-06-25","scope":"insider"},{"id":2336293,"accession":"0001209191-20-026072","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-026072","line_url":"/filing/0001209191-20-026072#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001727606","owner_name":"ROBERTS EIRY","owner_display_name":"ROBERTS EIRY","owner_url":"/insider/0001727606","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1934.0,"shares_display":"1,934","price_per_share":99.4707,"price_display":"99.47","price_state":"stated","total_value":192376.3338,"total_display":"192,376.33","total_whole":"192,376","shares_owned_after":9416.0,"shares_owned_after_display":"9,416","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-24","filed_date":"2020-04-28","scope":"insider"},{"id":3295198,"accession":"0001209191-20-008518","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-008518","line_url":"/filing/0001209191-20-008518#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001727606","owner_name":"ROBERTS EIRY","owner_display_name":"ROBERTS EIRY","owner_url":"/insider/0001727606","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1623.0,"shares_display":"1,623","price_per_share":103.312,"price_display":"103.31","price_state":"stated","total_value":167675.376,"total_display":"167,675.38","total_whole":"167,675","shares_owned_after":7452.0,"shares_owned_after_display":"7,452","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-07","filed_date":"2020-02-11","scope":"insider"},{"id":2624486,"accession":"0001209191-20-003043","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-003043","line_url":"/filing/0001209191-20-003043#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001727606","owner_name":"ROBERTS EIRY","owner_display_name":"ROBERTS EIRY","owner_url":"/insider/0001727606","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2632.0,"shares_display":"2,632","price_per_share":111.1113,"price_display":"111.11","price_state":"stated","total_value":292444.9416,"total_display":"292,444.94","total_whole":"292,445","shares_owned_after":5991.0,"shares_owned_after_display":"5,991","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-08","filed_date":"2020-01-10","scope":"insider"},{"id":7874581,"accession":"0001209191-19-003276","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-003276","line_url":"/filing/0001209191-19-003276#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001727606","owner_name":"ROBERTS EIRY","owner_display_name":"ROBERTS EIRY","owner_url":"/insider/0001727606","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1857.0,"shares_display":"1,857","price_per_share":84.0919,"price_display":"84.09","price_state":"stated","total_value":156158.6583,"total_display":"156,158.66","total_whole":"156,159","shares_owned_after":3143.0,"shares_owned_after_display":"3,143","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-08","filed_date":"2019-01-10","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":40,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":40,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":40},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000914475","name":"NEUROCRINE BIOSCIENCES INC","url":"/issuer/0000914475","role":"Officer (Chief Medical Officer)","n_filings":25,"first_seen":"2019-01-10","last_seen":"2025-02-14"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001727606","retrieved_at":"2026-08-22T11:45:02+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}